Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1733-1743

  Al Marzoqee, Fathyia Y ^a   Khoder, Ghalia ^a,c   Al Awadhi, Haifa ^a   John, Rony ^a   Beg, Azam ^a   Vincze, Aron ^b,d   Branicki, Frank ^a   Karam, Sherif M ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

^c AL AIN UNIVERSITY   (United Arab Emirates)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Gastric cancer; Gastric stem cell; Gastritis; Octamer binding transcription factor 4; Stomach

Indexed keywords

ANTIBODY; FUCOSE; LECTIN; N ACETYLGLUCOSAMINE; OCTAMER TRANSCRIPTION FACTOR 4;

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL PROLIFERATION; DYSPLASIA; FEMALE; GASTRECTOMY; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; INFORMED CONSENT; MALE; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; TISSUE SECTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEOLUS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN TRANSPORT; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84867771542     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1608     Document Type: Article

References (39)

1. Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
2. Correa P: Is gastric cancer preventable? Gut 53: 1217-1219, 2004.
3. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K and Hattori T: Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 9: 177-184, 2006 (Pubitemid 44426890)
4. Correa P, Piazuelo MB and Camargo MC: Etiopathogenesis of gastric cancer. Scand J Surg 95: 218-24, 2006. (Pubitemid 46089254)
5. Fox JG and Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest 117: 60-69, 2007. (Pubitemid 46048450)
6. Karam SM: Mouse models demonstrating the role of stem/progenitor cells in gastric carcinogenesis. Front Biosci 15: 595-603, 2010.
7. Lee ER and Leblond CP: Dynamic histology of the antral epithelium in the mouse stomach: II. Ultrastructure and renewal of isthmal cells. Am J Anat 172: 205-224, 1985. (Pubitemid 15149011)
8. Karam SM: Lineage commitment and maturation of epithelial cells in the gut. Front Biosci 4: D286-D298, 1999.
9. Barker N, Huch M, Kujala P van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R and Clevers H: Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6: 25-36, 2010.
10. Karam SM, Tomasetto C and Rio MC: Trefoil factor 1 is required for the commitment programme of mouse oxyntic epithelial progenitors. Gut 53: 1408-1415, 2004. (Pubitemid 39265257)
11. Karam SM, Tomasetto C and Rio MC: Amplification and invasiveness of gastric epithelial progenitors during carcinogenesis in TFF1-knockout mice. Cell Prolif 41: 923-935, 2008.
12. Al-Awadhi H, John R, Al-Marzooqi F, Vincze A, Branicki F and Karam SM: Sequential alterations in gastric biopsies and tumor tissues support the multistep process of carcinogenesis. Histol Histopath 26: 1153-1164, 2011.
13. Trosko JE and Chang CC: Stem cell theory of carcinogenesis. Toxicol Lett 49: 283-295, 1989. (Pubitemid 20009685)
14. Sell S: On the stem cell origin of cancer. Am J Pathol 176: 2584-2594, 2010.
15. Katoh M and Katoh M: WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045, 2007. (Pubitemid 47105963)
16. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M and Hamada H: A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60: 461-472, 1990.
17. Thomas T, Nowka K, Lan L and Derwahl M: Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid 16: 537-544, 2006. (Pubitemid 44066260)
18. Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, Herlyn M and Xu X: Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 168: 1879-1888, 2006. (Pubitemid 43825308)
19. Sotomayor P, Godoy A, Smith GJ and Huss WJ: Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate 69: 401-410, 2009.
20. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK and Trosko JE: Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26: 495-502, 2005. (Pubitemid 40246573)
21. Hochedlinger K, Yamada Y, Beard C and Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477, 2005. (Pubitemid 40692305)
22. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G and Oosterhuis JW: POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244-2250, 2003. (Pubitemid 36538633)
23. Ezeh UI, Turek PJ, Reijo RA and Clark AT: Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265, 2005. (Pubitemid 41579973)
24. Iki K and Pour PM: Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model. Pancreatology 6: 406-413, 2006. (Pubitemid 44329087)
25. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and Steindler DA: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7: 967-976, 2005.
26. Stolte M and Meining A: The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol 15: 591-598, 2001. (Pubitemid 33062055)
27. Karam SM, Li Q and Gordon JI: Gastric epithelial morphogenesis in normal and transgenic mice. Am J Physiol 272: G1209-G1220, 1997.
28. Farook VS, Alkhalaf M and Karam SM: Establishment of a gastric epithelial progenitor cell line from a transgenic mouse expressing the simian virus 40 large T antigen gene in the parietal cell lineage. Cell Prolif 41: 310-320, 2008. (Pubitemid 351367497)
29. Liedtke S, Stephan M and Kogler G: Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 389: 845-850, 2008.
30. Zuk PA: The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used. J Cell Biochem 106: 867-877, 2009.
31. Wang X and Dai J: Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells 28: 885-893, 2010.
32. Chen Z, Xu WR, Qian H, Zhu W, Bu XF, Wang S, Yan YM, Mao F, Gu HB, Cao HL and Xu XJ: Oct4, a novel marker for human gastric cancer. J Surg Oncol 99: 414-419, 2009.
33. Graham DY, Opekun AR, Yamaoka Y, Osato MS and el-Zimaity HM: Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 17: 193-200, 2003. (Pubitemid 36174249)
34. Ji H and Yardley JH: Iron medication-associated gastric mucosal injury. Arch Pathol Lab Med 128: 821-822, 2004. (Pubitemid 38856903)
35. Zangrossi S, Marabese M, Broggini M, Giordano R, D'Erasmo M, Montelatici E, Intini D, Neri A, Pesce M, Rebulla P and Lazzari L: Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25: 1675-1680, 2007. (Pubitemid 47121844)
36. Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J and Atlasi Y: OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int J Cancer 128: 2645-2652, 2011.
37. Niwa H, Miyazaki J and Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376, 2000. (Pubitemid 30187435)
38. + cells in adult tissues. Stem Cell Rev 6: 307-316, 2010.
39. Sell S: Cancer and stem cell signaling: a guide to preventive and therapeutic strategies for cancer stem cells. Stem Cell Rev 3: 1-6, 2007.